Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

For IBS, specific diets are less important than expected

Many IBS sufferers avoid certain types of food and often exclude gluten. However, a large new study from Chalmers University of Technology and Uppsala University, Sweden, does not show a relationship between high intake of gluten and increased IBS symptoms. The researchers did find that a certain type of carbohydrate called ‘fodmaps’ can aggravate intestinal problems, however, the overall results indicate that they also have less influence than previously thought.“IBS is a very complex disease involving many factors, but our results indicate that the effects of specific diets

Embracer Group successfully completed a directed issue of 69,000,000 new B shares raising proceeds of roughly SEK 6 billion

INSIDE INFORMATION: Embracer Group AB (the "Company" or “Embracer Group”) has, as announced in its press release on December 15, 2021, carried out an issue of 69,000,000 new B shares directed to Swedish and international institutional investors, resolved upon by the Board of Directors based on the authorization from the annual general meeting on September 16, 2021 (the "Share Issue"). The subscription price in the Share Issue is SEK 87 per B share and has been determined through an accelerated book-building procedure led by Nordea Bank Abp, filial i Sverige, HSBC Continental Europe,

Getinge reinvents office work in the South Asia Pacific region

As a trailblazer within remote working, the global medtech company Getinge’s implementation of a long-term flexible workplace approach in the South Asia-Pacific (SAPAC) region has been a success. The acceptance rate among employees is over 90 per cent in the markets that have already implemented the concept.What started as a health and safety measurement in the early days of the COVID-19 outbreak, has turned into an established way of working in Getinge’s worldwide organization, with the objective to offer employees with position eligible for remote work a possibility to choose flexibility.

The exercise price for the warrants of series TO1 in GET Group AB (publ) has been determined to approximately SEK 0.104

GET Group AB (publ) (”GET Group” or the ”Company”) completed during December 2020 an rights issue of units consisting of one (1) new share and one (1) free of charge warrant of series TO1. In total, 41,008,175 warrants of series TO1 was issued. Each warrant entitles the holder to subscribe for one (1) new share in the Company during the period from and including 16 December 2021 to and including 30 December 2021. The exercise price per share is to be determined to 70 percent of the volume-weighted average price in the Company’s share on NGM Nordic SME during the measurement period from and

Braeburn receives new Complete Response Letter for Brixadi in the US

Lund, Sweden — 15 December 2021 — Camurus AB (NASDAQ STO: CAMX) today announced that its US licensee Braeburn has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) for its updated New Drug Application (NDA) for Brixadi™ (buprenorphine) extended-release injections for the treatment of opioid use disorder. The CRL is a result of continued quality related deficiencies at Braeburn’s US based third party manufacturer, identified by the FDA during a pre-approval inspection. “We are very disappointed to learn of the new Complete Response Letter for Brixadi

Checkin.com successfully completes a directed share issue raising proceeds of approximately SEK 56 million

Checkin.com Group AB (STO:CHECK) (“Checkin.com Group” or the “Company”) has, as announced in its press release on December 15, 2021, carried out an issue of 1 million new shares directed to institutional investors, resolved upon by the Board of Directors based on the authorization from the annual general meeting on April 26, 2021 (the “Directed Share Issue”). The subscription price in the Directed Share Issue was SEK 56 per share and has been determined through an accelerated book-building procedure led by Carnegie Investment Bank AB (publ) and Erik Penser Bank AB (jointly referred to as the "

New research article demonstrates the potential for lab-on-chip catalysis using Attana technology

A recent article published in RSC Advances (Royal Society of Chemistry) illustrates how Attana gold coated surfaces functionalized with a combination of polyethyleneimine and palladium nanoparticles have been used as efficient catalysts and the potential for using this approach in lab-on-a-chip-based synthesis applications using the Attana Quartz Crystal Microbalance (QCM) system.Attana technology has been applied by the team of Prof Ian Nicholls at Linnaeus University, in their development of a flow microreactor for catalyzes of a series of Suzuki reactions. The recently published RSC

Nordea Bank Abp: Repurchase of own shares on 15.12.2021

Nordea Bank AbpStock exchange release – Changes in company’s own shares15.12.2021 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 15.12.2021 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 940,126 10.35 9,730,837.61XHEL 656,940 10.34 6,794,730.42CEUX 842,223 10.35 8,715,696.42AQEU 135,906 10.34

Intervacc comments on the trading halt of the company's share on Nasdaq First North

Stockholm, December 15, 2021 - Nasdaq Stockholm has decided to temporarily stop trading in Intervacc after a volatile trading session and a decline in the share price. The reason for the price decline is speculation in social media about the company's vaccine Strangvac, following the Medical Products Agency having published a so-called monograph on the vaccine. The Medical Products Agency states in the monograph: “Experience has shown that it is difficult to produce a vaccine against strangles that can effectively prevent horses from becoming infected, spreading infection and developing

Trading of own shares as part of employee’s savings scheme

SpareBank 1 SR-Bank ASA has on 15 December 2021 purchased 30 000 own shares at an average price of NOK 123,8868 Total holdings of own shares after the purchase is 71 273 shares. The shares were acquired as part of SpareBank 1 SR-Bank’s savings scheme for employees. For more information about the saving scheme reference is made to the stock exchange notice dated 10 December 2020, and the stock exchange notice dated 29 April 2021. As part of SpareBank 1 SR-Bank ASA savings scheme the company will acquire additional shares, up to a number of 75 000, within 31 December 2021.

Commencement of new plan periods in long-term incentive plans targeted to Metso Outotec management and key employees

Metso Outotec Corporation’s stock exchange release on December 15, 2021, at 7:10 p.m. EETThe Board of Directors of Metso Outotec Corporation has approved the commencement of a new plan period 2022-2024 in the following share-based long-term incentive programs of the Company: The Performance Share Plan (also "PSP") and the Restricted Share Plan (also "RSP"). Metso Outotec originally announced the establishment of the PSP and the RSP structure on July 1, 2020. PSP 2022-2024 PSP 2022-2024 is subject to achieving performance targets set by the Board of Directors, measured over a three-

NOTE presents new financial targets and sustainability goals

Today NOTE presents new financial targets and sustainability goals for the company. At tomorrow's Capital Markets Day, NOTE's Group Management will provide further insight into the company's operations, strategy, new financial targets and sustainability goals. NOTE's new financial target is that by 2025 at the latest: · Reach a sales level of at least SEK 5 billion.This should essentially be achieved through high organic growth complemented by carefully selected acquisitions. · Reach an operating margin of at least 10%. Other financial targets regarding capital structure and

Terveystalo Plc: SHARE REPURCHASE 15.12.2021

Terveystalo Plc ANNOUNCEMENT  15.12.2021 Terveystalo Plc: SHARE REPURCHASE 15.12.2021 In the Helsinki Stock Exchange Trade date           15.12.2021Bourse trade         BuyShare                  TTALOAmount             21 748 SharesAverage price/ share    11,1237 EURTotal cost            241 918,23 EUR Terveystalo Plc now holds a total of 1 507 017 sharesincluding the shares repurchased on 15.12.2021 On behalf of Terveystalo Plc Nordea Bank Oyj Janne

Targovax awarded NOK 9.8m research grant by the Research Council of Norway towards the TG mutant RAS program

Oslo, Norway, 15 December 2021 - Targovax ASA (OSE: TRVX) a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that the Research Council of Norway has awarded Targovax a NOK 9.8m research grant towards product and clinical development for the TG mutant KRAS cancer vaccine program.The Research Council of Norway has awarded the grant within the category “Innovation Project for the Industrial Sector”. Project title: “Development of targeted therapies for mutant RAS cancers”Awarded by: The Research Council of Norway

Embracer Group announces intention to carry out a directed share issue of approximately SEK 5.5 billion through new B shares

INSIDE INFORMATION: Embracer Group AB (the "Company" or “Embracer Group”) hereby announces its intention to carry out a directed share issue of approximately SEK 5.5 billion through new B shares, which is intended to be resolved upon by the Board of Directors based on the authorization granted by the annual general meeting on September 16, 2021 (the "Share Issue"). The Share Issue will be directed to Swedish and international institutional investors. Embracer Group has engaged Nordea Bank Abp, filial i Sverige, HSBC Continental Europe, Skandinaviska Enskilda Banken AB and Swedbank AB (publ) (

Invitation to Embracer Group’s presentation about the acquisition of Asmodee at 08:15 (CET)

Embracer Group hereby invites you to a presentation regarding today's press release headlined “Embracer Group intends to make a strategic acquisition of leading board gaming group Asmodee that would form the ninth operating group”.The presentation will be held in English by CEO Lars Wingefors and by the management of Asmodee; Stéphane Carville CEO, Marc Nunes Head of board games, Thomas Koegler Head of Strategy, and Gaëlle d’Engremont, Partner and Head of Food & Consumer sector at PAI Partners. A Q&A session will follow the presentation, led by an equity research analyst covering Embracer

Checkin.com Group announces intention to carry out a directed share issue

Checkin.com Group AB, (STO:CHECK) (“Checkin.com Group” or the “Company”) hereby announces its intention to carry out an directed share issue, with deviation from the shareholders' preferential rights, of approximately 900 thousand new shares (approximately 3% of outstanding share capital) directed to institutional investors through an accelerated book-building procedure pursuant to the authorization granted by an Annual General Meeting held on April 26, 2021 (the “Directed Share Issue”). Checkin.com Group has engaged Carnegie Investment Bank AB (publ) and Erik Penser Bank AB to explore the

Checkin.com Group acquires tech company specialized within AI

INSIDER INFORMATION: Checkin.com Group (STO:CHECK), the tech company that changes how people all over the world checkin with services online, has today entered into an agreement to acquire all shares in the Estonian tech company DATACORP OÜ (DATACORP). DATACORP and its co-workers are specialized in developing AI software for image analysis based on neural network algorithms, computer vision and machine learning. Checkin.com Group assesses the acquired technology and knowledge to be a crucial piece of the puzzle in their ongoing development of the next generation checkin solutions.The

Embracer Group intends to make a strategic acquisition of leading board gaming group Asmodee that would form the ninth operating group

INSIDE INFORMATION: Embracer Group AB ("Embracer"), has today entered into exclusive negotiations to acquire Financière Amuse Topco SAS (“Asmodee”) from funds advised or managed by PAI Partners SAS (“PAI”) and the other shareholders of Asmodee. Subject to completion of the consultation of the relevant works council of the Asmodee group on this proposed transaction, and exercise by the shareholders of Asmodee of their option to sell, Embracer and the shareholders of Asmodee would execute a share purchase agreement to complete the transaction. If the acquisition is eventually completed, it

#21-414 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Neles’ financial information in 2022

Neles Corporation, Stock exchange release, December 15, 2021, at 6:15 p.m. EETNeles Corporation will publish the following financial information in 2022: The Financial Statements Review for 2021 will be published on February 4, 2022, if the merger with Valmet has not closed prior to this. The silent period starts on January 5, 2021. Neles’ Annual General Meeting 2022 is planned to be held on March 22, 2022, if the merger with Valmet does not close before February 28, 2022. Neles' Board of Directors will convene the meeting by separate invitation. The Financial Statements for 2021

Balder’s outlook changed to stable from negative by S&P

On October 18, 2021, S&P announced that they changed Balder’s outlook from stable to negative due to Balder’s mandatory bid on Entra ASA (”Entra”) and the uncertainty regarding the initial funding structure. As only 2.37% of Entra’s shareholders accepted the offer, S&P has now revised the outlook back to stable. Balder has previously communicated that they will take the steps necessary to maintain a BBB stable rating. It is therefore gratifying to announce after only two months that the negative outlook has been revised back to stable. For further information, please contact:CEO

Veidekke ASA: Building new car parking at Stavanger Airport, Sola

Veidekke has won the competition and now signed a contract with Avinor to rebuild the parking garage at Stavanger Airport, Sola, after the fire almost two years ago. This is a design and build contract with a value of NOK 360 million, excluding VAT.The new car park will have a 65,000 m[2] floor area over five floors and accommodate approximately 2,300 cars, just like the previous parking garage that suffered the extensive fire in January 2020. But unlike the previous car park, the new one is divided into two fire sections and fully covered by sprinklers, making this one of Norway’s most

New Firearms book gauges extent of global problem

ACADEMICS researching gun-crime have published a book which gives sight of a global problem which claims more than 200,000 lives a year.Firearms: Global Perspectives on Consequences, Crime and Control  published by Routledge, explores the illicit use of firearms across the globe, including legal, social science, technical and research perspectives on the issue. Co-edited by Dr Helen Poole, Executive Dean of the School of Crime, Justice and Security at Staffordshire

There are no items matching the current filter
There are no more items matching the current filter
Back to top